The anti-inflammatory efficacy of dexamethasone is protected by (-)-epicatechin

PharmaNutrition

Volumn 2, Issue 2, 2014, Pages 47-52

  Ruijters, Erik J B ^a   Haenen, Guido R M M ^a   Weseler, Antje R ^a   Bast, Aalt ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

( ) Epicatechin; Chronic inflammation; Dexamethasone; Glucocorticoid resistance; Oxidative stress

Indexed keywords

DEXAMETHASONE; EPICATECHIN; HYDROGEN PEROXIDE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL STRESS; CELLULAR STRESS RESPONSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG POTENCY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG TARGETING; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84899738376     PISSN: None     EISSN: 22134344     Source Type: Journal    
DOI: 10.1016/j.phanu.2014.04.001     Document Type: Article

References (35)

1. Rickard A.J., Young M.J. Corticosteroid receptors, macrophages and cardiovascular disease. Journal of Molecular Endocrinology 2009, 42:449-459. http://www.ncbi.nlm.nih.gov/pubmed/19158233, 10.1677/JME-08-0144.
2. Hakim A., Adcock I.M., Usmani O.S. Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction. Drugs 2012, 72:1299-1312. http://www.ncbi.nlm.nih.gov/pubmed/22731962, 10.2165/11634350-000000000-00000.
3. De Iudicibus S., Franca R., Martelossi S., Ventura A., Decorti G. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World Journal of Gastroenterology: WJG 2011, 17:1095-1108. http://www.ncbi.nlm.nih.gov/pubmed/21448414, 10.3748/wjg.v17.i9.1095.
4. Yang N., Ray D.W., Matthews L.C. Current concepts in glucocorticoid resistance. Steroids 2012, 77:1041-1049. http://www.ncbi.nlm.nih.gov/pubmed/22728894, 10.1016/j.steroids.2012.05.007.
5. Farrell R.J., Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. Journal of Endocrinology 2003, 178:339-346. http://www.ncbi.nlm.nih.gov/pubmed/12967327, 10.1677/joe.0.1780339.
6. Whitehouse M.W. Anti-inflammatory glucocorticoid drugs: reflections after 60 years. Inflammopharmacology 2011, 19:1-19. http://www.ncbi.nlm.nih.gov/pubmed/21072600, 10.1007/s10787-010-0056-2.
7. Milara J., Navarro A., Almudever P., Lluch J., Morcillo E.J., Cortijo J. Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophages. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2011, 41:535-546. http://www.ncbi.nlm.nih.gov/pubmed/21395877, 10.1111/j.1365-2222.2011.03715.x.
8. Adcock I.M., Barnes P.J. Molecular mechanisms of corticosteroid resistance. Chest 2008, 134:394-401. http://www.ncbi.nlm.nih.gov/pubmed/18682458, 10.1378/chest.08-0440.
9. Roche N., Marthan R., Berger P., Chambellan A., Chanez P., Aguilaniu B., et al. Beyond corticosteroids: future prospects in the management of inflammation in COPD. European Respiratory Review: An Official Journal of the European Respiratory Society 2011, 20:175-182. http://www.ncbi.nlm.nih.gov/pubmed/21881145, 10.1183/09059180.00004211.
10. Hazewindus M., Haenen G.R.M.M., Weseler A.R., Bast A. The anti-inflammatory effect of lycopene complements the antioxidant action of ascorbic acid and α-tocopherol. Food Chemistry 2012, 132:954-958. 10.1016/j.foodchem.2011.11.075.
11. Rahman I., Biswas S.K., Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology 2006, 72:1439-1452. http://www.ncbi.nlm.nih.gov/pubmed/16920072, 10.1016/j.bcp.2006.07.004.
12. van den Berg R., Haenen G.R., van den Berg H., Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. British Journal of Nutrition 2001, 86(Suppl. 1):S121-S127. http://www.ncbi.nlm.nih.gov/pubmed/11520430, 10.1079/BJN2001340.
13. Steinberg F.M., Bearden M.M., Keen C.L. Cocoa and chocolate flavonoids: implications for cardiovascular health. Journal of the American Dietetic Association 2003, 103:215-223. http://www.ncbi.nlm.nih.gov/pubmed/12589329, 10.1053/jada.2003.50028.
14. Corcoran M.P., McKay D.L., Blumberg J.B. Flavonoid basics: chemistry, sources, mechanisms of action, and safety. Journal of Nutrition in Gerontology and Geriatrics 2012, 31:176-189. http://www.ncbi.nlm.nih.gov/pubmed/22888837, 10.1080/21551197.2012.698219.
15. Soobrattee M.A., Neergheen V.S., Luximon-Ramma A., Aruoma O.I., Bahorun T. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutation Research 2005, 579:200-213. http://www.ncbi.nlm.nih.gov/pubmed/16126236, 10.1016/j.mrfmmm.2005.03.023.
16. Peluso I., Raguzzini A., Serafini M. Effect of flavonoids on circulating levels of TNF-alpha and IL-6 in humans: a systematic review and meta-analysis. Molecular Nutrition and Food Research 2013, 57:784-801. 10.1002/mnfr.201200721.
17. Ruijters E.J., Weseler A.R., Kicken C., Haenen G.R., Bast A. The flavanol (-)-epicatechin and its metabolites protect against oxidative stress in primary endothelial cells via a direct antioxidant effect. European Journal of Pharmacology 2013, 715:147-153. http://www.ncbi.nlm.nih.gov/pubmed/23747595, 10.1016/j.ejphar.2013.05.029.
18. Ruijters E.J., Haenen G.R., Weseler A.R., Bast A. The cocoa flavanol (-)-epicatechin protects the cortisol response. Pharmacological Research: The Official Journal of the Italian Pharmacological Society 2014, 79:28-33. http://www.ncbi.nlm.nih.gov/pubmed/24269961, 10.1016/j.phrs.2013.11.004.
19. Del Rio D., Rodriguez-Mateos A., Spencer J.P., Tognolini M., Borges G., Crozier A. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants and Redox Signaling 2013, 18:1818-1892. http://www.ncbi.nlm.nih.gov/pubmed/22794138, 10.1089/ars.2012.4581.
20. 2 in cell cultures: impact of cell concentration and exposure time. Free Radical Biology & Medicine 2010, 49:1298-1305. http://www.ncbi.nlm.nih.gov/pubmed/20673847, 10.1016/j.freeradbiomed.2010.07.015.
21. Buttgereit F. A fresh look at glucocorticoids how to use an old ally more effectively. Bulletin of the NYU Hospital for Joint Diseases 2012, 70(Suppl. 1):26-29. http://www.ncbi.nlm.nih.gov/pubmed/23259655.
22. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids- new mechanisms for old drugs. New England Journal of Medicine 2005, 353:1711-1723. http://www.ncbi.nlm.nih.gov/pubmed/16236742, 10.1056/NEJMra050541.
23. Barnes P.J., Adcock I.M. Glucocorticoid resistance in inflammatory diseases. Lancet 2009, 373:1905-1917. http://www.ncbi.nlm.nih.gov/pubmed/19482216, 10.1016/S0140-6736(09)60326-3.
24. Mittal M., Siddiqui M.R., Tran K., Reddy S.P., Malik A.B. Reactive oxygen species in inflammation and tissue injury. Antioxidants & Redox Signaling 2014, 20:1126-1167. http://www.ncbi.nlm.nih.gov/pubmed/23991888, 10.1089/ars.2012.5149.
25. Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., van Herwaarden C.L., et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1996, 154:813-816. http://www.ncbi.nlm.nih.gov/pubmed/8810624, 10.1164/ajrccm.154.3.8810624.
26. Segal A.W. How neutrophils kill microbes. Annual Review of Immunology 2005, 23:197-223. http://www.ncbi.nlm.nih.gov/pubmed/15771570, 10.1146/annurev.immunol.23.021704.115653.
27. Hakim A., Barnes P.J., Adcock I.M., Usmani O.S. Importin-7 mediates glucocorticoid receptor nuclear import and is impaired by oxidative stress, leading to glucocorticoid insensitivity. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2013, 27:4510-4519. http://www.ncbi.nlm.nih.gov/pubmed/23934279, 10.1096/fj.12-222604.
28. Ito K., Hanazawa T., Tomita K., Barnes P.J., Adcock I.M. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: Role of tyrosine nitration. Biochemical and Biophysical Research Communications 2004, 315:240-245. http://www.ncbi.nlm.nih.gov/pubmed/15013452, 10.1016/j.bbrc.2004.01.046.
29. Li L.B., Leung D.Y., Martin R.J., Goleva E. Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma. American Journal of Respiratory and Critical Care Medicine 2010, 182:877-883. http://www.ncbi.nlm.nih.gov/pubmed/20538962, 10.1164/rccm.201001-0015OC.
30. Rossios C., To Y., Osoata G., Ito M., Barnes P.J., Ito K. Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition. British Journal of Pharmacology 2012, 167:775-786. http://www.ncbi.nlm.nih.gov/pubmed/22251095, 10.1111/j.1476-5381.2012.01864.x.
31. Barnes P.J. Glucocorticosteroids: current and future directions. British Journal of Pharmacology 2011, 163:29-43. http://www.ncbi.nlm.nih.gov/pubmed/21198556, 10.1111/j.1476-5381.2010.01199.x.
32. Meja K.K., Rajendrasozhan S., Adenuga D., Biswas S.K., Sundar I.K., Spooner G., et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. American Journal of Respiratory Cell and Molecular Biology 2008, 39:312-323. http://www.ncbi.nlm.nih.gov/pubmed/18421014, 10.1165/rcmb.2008-0012OC.
33. Bast A., Haenen G.R. Ten misconceptions about antioxidants. Trends in Pharmacological Sciences 2013, 34:430-436. http://www.ncbi.nlm.nih.gov/pubmed/23806765, 10.1016/j.tips.2013.05.010.
34. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology 2008, 585:325-337. http://www.ncbi.nlm.nih.gov/pubmed/18417116, 10.1016/j.ejphar.2008.03.008.
35. Weseler A.R., Bast A. Pleiotropic-acting nutrients require integrative investigational approaches: the example of flavonoids. Journal of Agricultural and Food Chemistry 2012, 60:8941-8946. http://www.ncbi.nlm.nih.gov/pubmed/22455609, 10.1021/jf3000373.